Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154360 | SCV000204023 | likely benign | not specified | 2016-02-25 | criteria provided, single submitter | clinical testing | p.Met1853Leu in exon 33 of PCDH15: This variant is not expected to have clinica l significance because it has been identified in 0.4% (61/16510) of South Asian chromosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145903555). Although this variant has been previously reported in compound heterozygosity with a pathogenic variant i n one Ashkenazi Jewish individual with Usher syndrome, it was also detected in 0 .32% (9/2836) of control chromosomes from various Ashkenazi and non-Ashkenazi Je wish populations. In addition, computational prediction tools and conservation a nalyses suggest that this variant may not impact the protein. In summary, due t o the frequency of this variant in the general population, it is likely benign. |
Labcorp Genetics |
RCV000879612 | SCV001022656 | benign | not provided | 2024-11-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001104785 | SCV001261672 | likely benign | Usher syndrome type 1 | 2017-06-24 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000879612 | SCV001778452 | likely benign | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30245029, 21569298, 18727382, 15028842, 12711741, 25262649, 20672374) |
Ce |
RCV000879612 | SCV004701348 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | PCDH15: BP4 |
Clinical Genetics, |
RCV000154360 | SCV001921743 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000879612 | SCV001969236 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826830 | SCV002080805 | likely benign | Usher syndrome type 1F | 2020-01-27 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004544404 | SCV004774383 | likely benign | PCDH15-related disorder | 2022-03-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |